Agents and Actions

, Volume 16, Issue 3–4, pp 179–182 | Cite as

Characterization of vascular histamine H1-receptors: Multiple affinity states of aortic histamine H1-receptor

  • Marija Čarman-Kržan
Histamine Receptors


We have shown that [3H]mepyramine labels histamine H1-receptor-binding sites in bovine aortic membranes. Further characterization of H1-receptors in this tissue was done by the interaction of an unlabelled histamine receptor agonist or antagonist, with the radioantagonist [3H]mepyramine-binding sites. The competition-binding assays have uncovered differences in the characteristics of the agonist/receptor interaction not shared by antagonists. Agonists interact in the heterogeneous manner with the radioantagonist-labelled sites, showing shallow competition curves with thenH 0.50–0.72, whereas antagonists were devoid of this effect (steeper slopes of the inhibition curvesnH≈1). The results suggest the presence in this tissue of multiple affinity states of histamine H1-receptor, differentiated by high and low affinity for agonists and the same affinity for antagonists.


Histamine Receptor Agonist Steep Slope Histamine Receptor Mepyramine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    M. Čarman-Kržan,Specific binding of [3 H]-mepyramine to histamine H 1-receptors in vascular smooth muscle membranes, Agents and Actions13, 162–166 (1983).PubMedGoogle Scholar
  2. [2]
    L. Toll andS. H. Snyder,Solubilization and characterization of histamine H 1-receptors in brain, J. biol. Chem.257, 13593–13601 (1982).PubMedGoogle Scholar
  3. [3]
    R. S. Kent, A. DeLean andR. J. Lefkowitz,A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data, Mol. Pharmacol.17, 14–23 (1980).PubMedGoogle Scholar
  4. [4]
    D. C. U'Prichard, J. C. Mitrius, D. J. Kahn andB. D. Perry, Theα 2 adrenergic receptors: multiple affinity states and regulation of a receptor inversely coupled to adenyalate cyclase. InMolecular Pharmacology of Neurotransmitter Receptors, pp. 53–72 (EdsT. Segawa et al.). Raven Press, New York 1983.Google Scholar
  5. [5]
    H. I. Yamamura, S. J. Enna andM. J. Kuhar,Neurotransmitter Receptor Binding, Raven Press, New York 1978.Google Scholar
  6. [6]
    M. Čarman-Kržan,Alpha adrenergic receptors in beef aortic membranes characterised by [3 H]dihydroergocryptine binding, Archs. int. Pharmacodyn. Thér.246, 237–250 (1980).Google Scholar
  7. [7]
    Y. C. Cheng andW. H. Prusoff,Relationship between the inhibition constant (K i)and the concentration of inhibitor which causes 50 per cent inhibition (IC 50)of an enzymatic reaction, Biochem. Pharmac.22, 3099–3108 (1973).CrossRefGoogle Scholar
  8. [8]
    G. J. Durant, W. A. M. Duncan, C. R. Ganellin, M. E. Parsons, R. C. Blakemore, A. C. Rasmussen,Impromidine (SK &F 02676) is a very potent and specific agonist for histamine H 2 receptors, Nature276, 403–405 (1978).PubMedGoogle Scholar
  9. [9]
    S. N. Abramson andP. B. Molinoff,In vitro interactions of agonists and antagonists with β-adrenergic receptors, Biochem. Pharmac.33, 869–875 (1984).CrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag 1985

Authors and Affiliations

  • Marija Čarman-Kržan
    • 1
  1. 1.Department of Pharmacology, Medical FacultyUniversity of LjubljanaLjubljanaYugoslavia

Personalised recommendations